Dendreon - 2/28

Entry	Author	Date	Location
Dendreon Whacks 500 Jobs, 25% of Workforce, After Missing Sales Goal	Luke Timmerman	09/08/11	Seattle
Oncothyreon CEO Bob Kirkman Takes Leave, Chairman Chris Henney to Fill In	Luke Timmerman	09/08/11	Seattle
Theraclone Sniffs Around for $10M, Dendreon Gets Third Factory OK, Zymeworks’ Big Merck Deal, & More Seattle-Area Life Sciences News	Luke Timmerman	09/08/11	Seattle
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead	Luke Timmerman	09/06/11	National
Dendreon Wins FDA OK for Atlanta Provenge Factory, Completing National Network	Luke Timmerman	08/26/11	Seattle
Seattle Genetics’ Market Debut, Pathway Gets Bought, Theraclone’s Latest Trick Against HIV, & More Seattle-Area Life Sciences News	Luke Timmerman	08/25/11	Seattle
Video: Seattle Genetics CEO Makes the Case for a $100K Cancer Drug	Luke Timmerman	08/22/11	Seattle
Dendreon Adds Ex-ImClone CEO to Board	Luke Timmerman	08/22/11	Seattle
Seattle Genetics: The Next Litmus Test for High Priced Cancer Drugs	Luke Timmerman	08/22/11	National
Adventrx Shares Plummet, Pfizer Adds UC San Diego to its Network, New RNAi Center Opens, & More San Diego Life Sciences News	Bruce V. Bigelow	08/11/11	San Diego
Dendreon’s Blow-Up, Epigenomics Leaves Town, Presage Adds $1.5M, & More Seattle-Area Life Sciences News	Luke Timmerman	08/11/11	Seattle
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus	Luke Timmerman	08/08/11	National
An Open Letter to Dendreon’s Chairman	Brad Loncar	08/05/11	Seattle
Dendreon Takes Huge Hit, Stock Tanks 60% on Sales Shortfall	Luke Timmerman	08/03/11	Seattle
Dendreon Misses Street Expectations, Plans Layoffs, Backs Away from Bullish Forecast	Luke Timmerman	08/03/11	Seattle
SeaGen Passes FDA Panel, Ken Stuart’s Journey to Seattle Biomed, the Latest M&A Obsession, & More Seattle-Area Life Sciences News	Luke Timmerman	07/21/11	Seattle
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent	Luke Timmerman	07/18/11	National
Seattle Genetics’ FDA Panel Preview: What You Need to Know This Week	Luke Timmerman	07/12/11	Seattle
SeaGen Preserves Science Culture, Dendreon Sways Medicare, NanoString’s Financing, & More Seattle-Area Life Sciences News	Luke Timmerman	07/07/11	Seattle
Dendreon, After Yearlong Inquiry, Sways Medicare to Pay for $93,000 Prostate Cancer Drug	Luke Timmerman	06/30/11	Seattle
Gates Bets on Computer Drug Discovery, Tachi Yamada Joins Frazier, Dendreon’s LA OK, & More in Seattle-Area Life Sciences News	Luke Timmerman	06/30/11	Seattle
Dendreon Gets FDA Nod for New LA Cancer Drug Factory	Luke Timmerman	06/29/11	Seattle
Orexigen Halts U.S. Work on Weight Loss Drug, Illumina Cuts Price for Sequencing Patient Genomes, Ambit Pulls IPO, & More San Diego Life Sciences News	Bruce V. Bigelow	06/09/11	San Diego
ASCO Wrap-Up, Pathway Medical Grinds It Out, Gates Foundation’s New Digs, & More in Seattle-Area Life Sciences News	Luke Timmerman	06/09/11	Seattle
ASCO Wrap-Up: The Skinny on Cancer News From All Corners of the U.S.	Luke Timmerman	06/07/11	National
Exelixis Zeroes in on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients	Luke Timmerman	06/06/11	San Francisco
The Quest For Biotech Independence: Maybe It Isn’t So Quixotic After All	Luke Timmerman	06/06/11	National
Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer	Luke Timmerman	05/24/11	Seattle
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired	Luke Timmerman	05/23/11	National
Finding a Solution To Our Biotech Malaise Together	Richard Gayle	05/18/11	Seattle
Page 2 of 10	« previous page · next page »

Entry

Author

Date

Location

Dendreon Whacks 500 Jobs, 25% of Workforce, After Missing Sales Goal

Luke Timmerman

09/08/11

Seattle

Oncothyreon CEO Bob Kirkman Takes Leave, Chairman Chris Henney to Fill In

Luke Timmerman

09/08/11

Seattle